News
The BC Cancer Foundation and BC Cancer Research Institute Announce the 2022 Rising Star Recipients!
Congratulations to the recipients of the inaugural BC Cancer Rising Stars Awards!
The Rising Stars program was established to celebrate Dr. Connie Eaves’ Gairdner Wightman Award, her election to the Royal Society in the UK and her appointment to the Order of Canada. A pioneer in her field, Dr. Eaves has been a mentor to many young researchers at BC Cancer and a long-time advocate for equal opportunities in cancer research.
Dr. Connie Eaves receives 2022 Till and McCulloch Lifetime Achievement Award
Each year, the Till and McCulloch Award celebrates the best of Canadian science in the stem cell and regenerative medicine field. This year, a special Till and McCulloch Lifetime Achievement Award will celebrate the outstanding contributions that Dr. Connie Eaves has made throughout her distinguished career. The Till and McCulloch Lifetime Achievement Award recognizes the career-spanning, pivotal contributions that Dr. Eaves has made to the field of stem cell research, as well as to the training of next generations of outstanding researchers.
Personalis in Partnership with BC Cancer to Assess Clinical and Economic Benefits of ctDNA for Colorectal and Pancreatic Cancers
Personalis’ Next Personal™ liquid biopsy assay will be deployed in study collaboration
Ly Vu awarded Michael Smith Health Research BC Scholar Award
Ly Vu has been awarded the Michael Smith Health Research BC Scholar Award for the project titled, "Post-transcriptional regulation of hematopoietic stem cell function during normal and malignant hematopoiesis."
The Michael Smith Health Research BC Scholar Program supports early-career health researchers who are building leading-edge health research programs, training the next generation of scientists and expanding their potential to make significant contributions to their field.
BC Cancer researchers part of international collaboration to develop treatments for osteosarcoma
BC Cancer researchers are playing a central role in a new international collaboration aimed at developing innovative treatments for osteosarcoma — a highly malignant bone cancer that commonly affects children and adolescents.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.